338 related articles for article (PubMed ID: 6377799)
21. Activity of ofloxacin against Mycobacterium leprae in the mouse.
Grosset JH; Guelpa-Lauras CC; Perani EG; Beoletto C
Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):259-64. PubMed ID: 3045223
[TBL] [Abstract][Full Text] [Related]
22. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
[TBL] [Abstract][Full Text] [Related]
23. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
[TBL] [Abstract][Full Text] [Related]
24. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
Shepard CC; Van Landingham RM; Walker LL; Good RC
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
[TBL] [Abstract][Full Text] [Related]
25. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
[No Abstract] [Full Text] [Related]
26. Activity of two doses of rifampin against Mycobacterium leprae.
Husser JA; Traore I; Daumerie D
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
[TBL] [Abstract][Full Text] [Related]
27. Leprosy in Malaysia.
Jayalakshmi P
Malays J Pathol; 1994 Jun; 16(1):7-9. PubMed ID: 16329568
[TBL] [Abstract][Full Text] [Related]
28. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
Levy L; Peters JH
Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
[No Abstract] [Full Text] [Related]
29. The normal mouse in experimental chemotherapy.
Levy L
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):843-6. PubMed ID: 3325577
[No Abstract] [Full Text] [Related]
30. The activity of rifabutin against Mycobacterium leprae in armadillos.
Dhople AM; Williams SL
Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
[TBL] [Abstract][Full Text] [Related]
31. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
[TBL] [Abstract][Full Text] [Related]
33. Newer drugs in leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 2001 Jun; 69(2 Suppl):S14-8. PubMed ID: 11757174
[TBL] [Abstract][Full Text] [Related]
34. Effects of certain ayurvedic preparations on the multiplication of M. leprae in mouse foot-pads.
Bhatia VN; Dinda B; Balakrishnan S; Roy RG
Indian J Lepr; 1984; 56(4):970-1. PubMed ID: 6398346
[No Abstract] [Full Text] [Related]
35. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
36. Effect of brodimoprim on Mycobacterium leprae in vitro and in mouse foot-pads.
Dhople AM; Ortega I; Seydel JK; Gardner GD
Indian J Lepr; 1990; 62(1):76-86. PubMed ID: 2193064
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic regimens in leprosy.
Pattyn SR
Verh K Acad Geneeskd Belg; 1990; 52(4):301-10; discussion 310-2. PubMed ID: 2077778
[TBL] [Abstract][Full Text] [Related]
38. Utility of beige mouse in leprosy research.
Gangadharam PR; Dhople AM
Indian J Lepr; 1992; 64(4):475-81. PubMed ID: 1308522
[TBL] [Abstract][Full Text] [Related]
39. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
40. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]